A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to improve liver function.

Layne Keep will graduate from the University of Oklahoma this May, carrying on a century-old tradition in her family. Keep’s mother, grandmother, and great-grandmother all graduated from OU. Her great-grandmother, Laura Focht Morgan, graduated exactly 100 years before Layne in May 1925.

The University of Oklahoma Health Sciences has achieved a new Carnegie Classification for its research enterprise and medical school program from the American Council on Education and the Carnegie Foundation for the Advancement of Teaching.

Vice President for Research for Health Sciences Darrin Akins, Ph.D., will retire on Aug. 8. Starting May 19, Akins will transition to a special assistant role within the OU Health Sciences’ Office of the Senior Vice President and Provost, where he will continue supporting strategic initiatives.

Two University of Oklahoma researchers, Rodney Tweten, Ph.D., and Jizhong “Joe” Zhou, Ph.D., have been elected to the prestigious National Academy of Sciences, one of the highest honors a scientist can receive. OU is the only university in Oklahoma with representation in the organization, and this marks the first time two OU faculty members have been elected in the same year.